Clinical value of selected markers of angiogenesis, inflammation, insulin resistance and obesity in type 1 endometrial cancer

被引:0
作者
Katarzyna M. Terlikowska
Bozena Dobrzycka
Robert Terlikowski
Anna Sienkiewicz
Maciej Kinalski
Slawomir J. Terlikowski
机构
[1] Medical University of Bialystok,Department of Food Biotechnology
[2] Medical University of Bialystok,Department of Gynecology and Obstetrics
[3] Medical University of Bialystok,Department of Rehabilitation
[4] Department of Gynecology and Obstetrics of the Independent Public Healthcare Facility Regional Complex Jan Sniadecki Hospital,Department of Obstetrics, Gynaecology and Maternity Care
[5] Medical University of Bialystok,undefined
来源
BMC Cancer | / 20卷
关键词
Obesity; Insulin resistance; Angiogenesis; Inflammation; Endometrial cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 218 条
[1]  
Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
[2]  
Ferlay J(2016)Endometrial cancer Lancet. 387 1094-1108
[3]  
Soerjomataram I(2014)Classification of endometrial carcinoma: more than two types Lancet Oncol 15 e268-e278
[4]  
Siegel RL(2010)Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study Endocr Relat Cancer 17 1007-1019
[5]  
Torre LA(2017)Endometrial Cancer: is this a new disease? Am Soc Clin Oncol Educ Book 37 435-442
[6]  
Jemal A(2010)Biomarkers as prognostic factors in endometrial cancer Folia Histochem Cytobiol 48 319-322
[7]  
Morice P(2016)Obesity and endometrial Cancer Recent Results Cancer Res 208 107-136
[8]  
Leary A(2017)Changes in inflammatory endometrial cancer risk biomarkers in individuals undergoing surgical weight loss Gynecol Oncol 147 133-138
[9]  
Creutzberg C(2011)A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers Cancer Epidemiol Biomark Prev 20 971-977
[10]  
Abu-Rustum N(2013)Case-control study of inflammatory markers and the risk of endometrial cancer Eur J Cancer Prev 22 374-379